pyrazines has been researched along with Allergic Cutaneous Angiitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexander, MP; Méndez, GP; Nasr, SH; Rennke, HG; Watson, DC | 1 |
Cho, CS; Eom, KS; Kim, CC; Kim, YJ; Lee, JW; Lee, S; Min, CK; Min, WS; Park, G | 1 |
Fang, B; Ma, J; Song, Y; Zhao, RC | 1 |
Astori, C; Castagnola, C; Corso, A; Lazzarino, M; Mangiacavalli, S; Varettoni, M; Zappasodi, P | 1 |
1 review(s) available for pyrazines and Allergic Cutaneous Angiitis
Article | Year |
---|---|
Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cutis Laxa; Dexamethasone; Diabetic Nephropathies; Erythropoietin; Fatal Outcome; Female; Heavy Chain Disease; Hematuria; Humans; Hypertension, Renal; Immunoglobulin alpha-Chains; Immunoglobulin gamma-Chains; Immunoglobulin mu-Chains; Kidney Glomerulus; Male; Multiple Myeloma; Paraproteinemias; Proteinuria; Pyrazines; Thalidomide; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous | 2011 |
3 other study(ies) available for pyrazines and Allergic Cutaneous Angiitis
Article | Year |
---|---|
Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines.
Topics: Boronic Acids; Bortezomib; Cytokines; Humans; Inflammation; Male; Middle Aged; Multiple Myeloma; Pyrazines; Skin; Vasculitis, Leukocytoclastic, Cutaneous | 2006 |
Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Dexamethasone; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Pyrazines; Stevens-Johnson Syndrome; Vasculitis, Leukocytoclastic, Cutaneous | 2007 |
Severe intestinal vasculitis in a patient under treatment with bortezomib.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Dexamethasone; Female; Gastrointestinal Hemorrhage; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Diseases; Middle Aged; Multiple Myeloma; Postoperative Complications; Pyrazines; Salvage Therapy; Vasculitis, Leukocytoclastic, Cutaneous | 2007 |